Veterinary Oncology Market Intelligence Report - Global Forecast to 2027

Veterinary Oncology Market Intelligence Report - Global Forecast to 2027

The Global Veterinary Oncology Market is projected to reach USD 105.08 million by 2027 from USD 62.28 million in 2021, at a CAGR 9.10% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

• The Americas Veterinary Oncology Market size was estimated at USD 24.61 million in 2021 and expected to reach USD 26.45 million in 2022, at a CAGR 8.57% to reach USD 40.33 million by 2027.
• The Asia-Pacific Veterinary Oncology Market size was estimated at USD 14.21 million in 2021 and expected to reach USD 15.72 million in 2022, at a CAGR 9.68% to reach USD 24.76 million by 2027.
• The Europe, Middle East & Africa Veterinary Oncology Market size was estimated at USD 23.45 million in 2021 and expected to reach USD 25.67 million in 2022, at a CAGR 9.29% to reach USD 39.99 million by 2027.

Market Segmentation & Coverage:

The report on veterinary oncology identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the veterinary oncology to forecast the revenues and analyze the trends in each of the following sub-markets:

Therapy:

• Chemotherapy
• Immunotherapy
• Radiology
• Surgery

Animal Type:

• Canine
• Feline

Cancer Type:

• Lymphoma
• Mammary and Squamous Cell Cancer
• Mast Cell Cancer

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • California
    • Florida
    • Illinois
    • New York
    • Ohio
    • Pennsylvania
    • Texas
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

Company Usability Profiles:

• AB Science SA
• C.H. Boehringer Sohn AG & Ko. KG
• Ceva Sante Animale S.A.
• Covetrus, Inc.
• Elanco Animal Health Incorporated
• Fidocure
• IDEXX Laboratories, Inc.
• Karyopharm Therapeutics
• Morphogenesis, Inc.
• Nippon Zenyaku Kogyo Co., Ltd.
• PetCure Oncology LLC
• PharmAust Limited
• Regeneus Ltd.
• Rhizen Pharmaceuticals AG
• Varian Medical Systems, Inc.
• VetDC, Inc.
• Vetoquinol S.A.
• Virbac SA